This week in the Clinical Trials/The Basics section of the CLL Society website, we’ve posted an interview with Dr. Jeff Sharman where we talked about how clinical trials are developing. We also reviewed some very important things that patients should know and do regardless of whether they are being treated within a trial.
For Patients Who Have Been Treated with Venetoclax: Lymphoma Canada is preparing a submission for the pan Canadian Oncology Drug Review (pCODR) for Venetoclax for the treatment of patients with chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) who have received at least one prior therapy; this includes patients with 17p deletion.
You can help by completing their survey, which will provide us with the patient input required for the submission. pCODR uses this information to help them make recommendations to the provinces and territories regarding funding for new cancer drugs.
You do not need to live in Canada to complete this survey. You can access the survey here. Consider taking the time to help out your fellow CLL patients in Canada. Thanks.
NEXT WEEK: We will be publishing the next issue of The CLL Tribune. You can look forward to:
- Reading/viewing an interview with Dr. Jeff Jones about Venetoclax from the recent EHA meeting in Copenhagen in Conference Coverage
- Read answers to reader questions by Dr. Rick Furman in Ask the Doctor
- Learn about what bone marrow does in The Basics Section
- In Beyond the Basics, find out about the ASCO sponsored TAPUR trial which is looking for new creative uses for already approved targeted therapies
- Learn new facts about CLL in the Did You Know section
- View some data from our most recent Reader Poll and share with us your opinions on CLL experts and whom you might recommend to other patients in our Ask & Tell section
- In Living Well with CLL, you can read about:
- Why You Should See a CLL Specialist
- How my Support Group Saved my Life
- I Don’t Have CLL. Yes, I Do. Now, I Don’t.
- On Being a Novice Patient
- May I Remember Never To Forget
In the meantime….
We are all in this together.
Brian Koffman, MD
Volunteer Medical Director of the CLL Society